Stay updated on Semaglutide vs Empagliflozin Once-Daily Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page.

Latest updates to the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page
- Check3 days agoChange DetectedRevision v3.3.4 has been added to the record history, and Revision v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed the HHS Vulnerability Disclosure link and deleted Revision: v3.3.2.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record history now includes an added revision entry for v3.3.2 and the v3.2.0 entry was removed from the versions list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check74 days agoChange DetectedRecord History shows updates to Study Status, Recruitment Status, and Eligibility across multiple versions with new submission dates. The changes reflect updated trial status and eligibility criteria.SummaryDifference0.1%

- Check103 days agoChange Detected- Added a prominent notice about potential data and processing delays due to funding lapse and updated operating status guidance, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

Stay in the know with updates to Semaglutide vs Empagliflozin Once-Daily Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Empagliflozin Once-Daily Clinical Trial page.